Combinations of Cyst(e)inase with a TXNR inhibitor (Auranofin) or a PARP inhibitor (Olaparib) further increased DNA damage and led to synergistic reduction of cell survival in culture and synergistic reduction in PCa tumor growth in xenograft tumor models. This evidence concerns the gene PARP1 and neoplasm.